• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results

    2/29/24 2:31:48 PM ET
    $DAVA
    $ENVB
    $HAYW
    $KA
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DAVA alert in real time by email

    U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.3% on Thursday.

    The Dow traded down 0.08% to 38,919.26 while the NASDAQ rose 0.53% to 16,032.35. The S&P 500 also rose, gaining, 0.30% to 5,084.84.

    Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Real estate shares rose by 1.2% on Thursday.

    In trading on Thursday, health care shares fell by 0.6%.

     

    Top Headline

     

    Shares of Hayward Holdings, Inc. (NYSE:HAYW) surged over 17% on Thursday after the company reported better-than-expected fourth-quarter results.

    Hayward Holdings posted adjusted earnings of 20 cents per share, beating market estimates of 18 cents per share. The company’s quarterly sales came in at $278.47 million versus expectations of $271.92 million.

     

    Equities Trading UP

     

    Societal CDMO, Inc. (NASDAQ:SCTL) shares shot up 130% to $1.06. Privately held CoreRx Inc. will acquire Societal CDMO, a contract development and manufacturing organization.

    Shares of Enveric Biosciences, Inc. (NASDAQ:ENVB) got a boost, surging 125% to $1.87. Enveric Biosciences signed a non-binding term sheets to pursue the exclusive out-licensing of three classes of compounds.

    Vertex, Inc. (NASDAQ:VERX) shares were also up, gaining 32% to $33.63 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance.

     

    Equities Trading DOWN

     

    LivePerson, Inc. (NASDAQ:LPSN) shares dropped 45% to $1.33 following fourth-quarter financial results.

    Shares of Endava plc (NYSE:DAVA) were down 39% to $38.90 following second-quarter earnings.

    Kineta, Inc. (NASDAQ:KA) was down, falling 46% to $1.2399 as the company announced intention to explore strategic alternatives.

    Also Check This Out: Top 3 Energy Stocks That Could Sink Your Portfolio In Q1

     

    Commodities

     

    In commodity news, oil traded up 0.1% to $78.56 while gold traded up 0.6% at $2,054.50.

    Silver traded rose 1.1% to $22.895 on Thursday while copper rose 0.1% to $3.8460.

     

    Euro zone

     

    European shares closed mixed today. The eurozone’s STOXX 600 rose 0.01%, London’s FTSE 100 rose 0.07% while Spain’s IBEX 35 Index fell 0.67% The German DAX gained 0.44% French CAC 40 fell 0.34% while Italy’s FTSE MIB Index declined 0.11%.

    German jobless rate held came in unchanged at 5.9% in February, while German retail sales fell by 0.4% month-over-month in January. Spanish annual consumer price inflation rate declined to a six-month low level of 2.8% in February.

    French economy expanded 0.1% on quarter in the fourth quarter. The annual inflation rate in France eased to 2.9% in February, while producer prices declined 1.3% month-over-month in January.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.11%, Hong Kong’s Hang Seng Index falling 0.15%, China’s Shanghai Composite Index gaining 1.94% and India’s S&P BSE Sensex gaining 0.27%.

    Indian fiscal deficit shrank to INR 11.03 trillion in April-January compared to INR 11.91 trillion in the year-ago period. Japanese housing starts fell by 7.5% year-over-year in January following a 4.0% decline in the previous month. Retail sales in Japan gained 2.3% year-over-year in January.

     

    Economics

     

    The annual PCE inflation rate eased slightly from 2.6% in December 2023 to 2.4% in January 2024. Excluding energy and food, the core PCE index saw a year-on-year surge of 2.8%, down from the 2.9% rate seen December and in line with the expected decrease to 2.8%.

    Personal spending rose by 0.2% from the previous month, while personal income rose by 1%.

    U.S. initial jobless claims rose by 13,000 to 215,000 in the week ending Feb. 24.

    The Chicago PMI declined to 44 in February from 46 in the previous month.

    Pending home sales in the U.S. fell by 4.9% from the prior month in January.

    U.S. natural-gas supplies fell 96 billion cubic feet of natural gas in the week ended Feb. 23, 2024.

    Now Read This: Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch

    Get the next $DAVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DAVA
    $ENVB
    $HAYW
    $KA

    CompanyDatePrice TargetRatingAnalyst
    Hayward Holdings Inc.
    $HAYW
    3/6/2026$19.00Underperform → Buy
    BofA Securities
    Vertex Inc.
    $VERX
    2/12/2026$16.00Buy → Hold
    Jefferies
    Vertex Inc.
    $VERX
    2/3/2026$20.00Overweight → Neutral
    Piper Sandler
    Endava plc
    $DAVA
    11/12/2025$12.00 → $9.00Buy
    Needham
    Endava plc
    $DAVA
    11/11/2025Outperform → Mkt Perform
    William Blair
    Vertex Inc.
    $VERX
    11/4/2025$30.00 → $24.00Outperform
    BMO Capital Markets
    Vertex Inc.
    $VERX
    9/26/2025$30.00Overweight
    Stephens
    Endava plc
    $DAVA
    9/5/2025$20.00 → $18.00Buy
    Guggenheim
    More analyst ratings

    $DAVA
    $ENVB
    $HAYW
    $KA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vertex Advances AI-Powered Capabilities to Improve How Enterprises Execute Compliance

    KING OF PRUSSIA, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) ("Vertex" or the "Company"), a leading provider of enterprise compliance technology for global commerce, today announced the next phase of its innovation strategy within the Vertex Cloud platform with new AI capabilities applied to improve how compliance work is executed as complexity continues to rise. As regulatory demands accelerate, tax, finance, and IT teams are under pressure to move faster while maintaining accuracy, accountability, and audit readiness. Many compliance challenges require interpretation, not just automation, and depend on complete, connected data. Teams are increasingly expected to r

    4/7/26 8:00:00 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates

    Patent provides added depth to Enveric's EVM301 intellectual property portfolio of potential neuroplastogenic molecules for non-hallucinogenic treatment of neuropsychiatric conditions Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that on March 17, 2026, it received U.S. Patent No. 12,577,232 ("the'232 patent") from the United States Patent and Trademark Office (USPTO) pertaining to its EVM301 Series of molecules. The EVM301 Series includes lead candidate, EB-003, being developed as potential treatments for mental health d

    3/31/26 8:00:00 AM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

    Product Development Highlights: Reported positive preclinical results for lead drug candidate EB-003, showing statistically significant improvements in animal models of severe chronic depression and despair and in post-traumatic stress disorder (PTSD) Identified neuroplastogen candidates with potential to promote brain-derived neurotrophic factor (BDNF) signaling, an established therapeutic target for neurodegenerative disease Corporate and Business Development Highlights: Announced the withdrawal of the Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals against Enveric's issued U.S. Patent No. 12,138,276, which appears relevant to the bretisilocin (GM-2505) mol

    3/27/26 5:40:00 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DAVA
    $ENVB
    $HAYW
    $KA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hollister Kathryn A

    4 - Endava plc (0001656081) (Issuer)

    4/2/26 5:55:09 PM ET
    $DAVA
    EDP Services
    Technology

    SEC Form 4 filed by Pattillo David Alexander

    4 - Endava plc (0001656081) (Issuer)

    4/2/26 5:55:11 PM ET
    $DAVA
    EDP Services
    Technology

    SEC Form 4 filed by Druskin Ben

    4 - Endava plc (0001656081) (Issuer)

    4/2/26 5:55:08 PM ET
    $DAVA
    EDP Services
    Technology

    $DAVA
    $ENVB
    $HAYW
    $KA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hayward Holdings upgraded by BofA Securities with a new price target

    BofA Securities upgraded Hayward Holdings from Underperform to Buy and set a new price target of $19.00

    3/6/26 8:18:36 AM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    Vertex downgraded by Jefferies with a new price target

    Jefferies downgraded Vertex from Buy to Hold and set a new price target of $16.00

    2/12/26 7:24:07 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Vertex downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Vertex from Overweight to Neutral and set a new price target of $20.00

    2/3/26 6:54:33 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    $DAVA
    $ENVB
    $HAYW
    $KA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Item Second Irr. Trust Fbo Kyle R. Westphal U/A Of Jeffrey R. Westphal Dated October 5, 2001 decreased direct ownership by 0.81% to 1,221,100 units (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    3/9/26 7:43:13 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    President and CEO Young Christopher David bought $730,794 worth of shares (60,000 units at $12.18) (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/25/26 4:15:34 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Director Andersen Eric C. bought $516,400 worth of shares (40,000 units at $12.91), increasing direct ownership by 36% to 150,341 units (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/23/26 4:47:08 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    $DAVA
    $ENVB
    $HAYW
    $KA
    SEC Filings

    View All

    SEC Form PRE 14A filed by Enveric Biosciences Inc.

    PRE 14A - Enveric Biosciences, Inc. (0000890821) (Filer)

    4/3/26 5:05:48 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Hayward Holdings Inc.

    DEF 14A - Hayward Holdings, Inc. (0001834622) (Filer)

    4/2/26 4:42:20 PM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    SEC Form DEFA14A filed by Hayward Holdings Inc.

    DEFA14A - Hayward Holdings, Inc. (0001834622) (Filer)

    4/2/26 4:36:45 PM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    $DAVA
    $ENVB
    $HAYW
    $KA
    Leadership Updates

    Live Leadership Updates

    View All

    Nexus Global Payments Appoints Technical Operator

    PayNet and NETS joint venture awarded contract to be Nexus Technical Operator, with support from Endava and AWS Nexus Global Payments (NGP) appoints Payments Network Malaysia (PayNet) and Network for Electronic Transfers Singapore (NETS) joint venture as the Nexus Technical Operator (NTO). This follows a competitive procurement process involving global bidders and marks a major milestone in building an interoperable global payments infrastructure. The evaluation of bidders considered technical capability, operational resilience, cost efficiency, and alignment with Nexus' vision for global interoperability. PayNet and NETS joint venture emerged as the preferred partner due to the proven

    2/9/26 6:21:00 AM ET
    $DAVA
    EDP Services
    Technology

    ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

    ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team. David Johnson, newly appointed Chairman of ENvue, stated, "We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the Company's unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping h

    12/15/25 9:00:00 AM ET
    $ENVB
    $FEED
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties

    Tripp Lane Joins LivePerson Board of Directors

    NEW YORK, Nov. 17, 2025 /PRNewswire/ -- LivePerson (NASDAQ:LPSN), a leading provider of predictable conversational AI and digital transformation, today announced that Nathan "Tripp" Lane has been appointed to its Board of Directors. "We are excited to welcome Tripp to the LivePerson Board," said Jim Miller, Board Chair. "Tripp's extensive experience guiding technology companies on strategy, operational effectiveness, and business transformation as a board director, operator, and investment advisor provides a unique perspective that will be an asset as we focus on execution and

    11/17/25 8:30:00 AM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    $DAVA
    $ENVB
    $HAYW
    $KA
    Financials

    Live finance-specific insights

    View All

    LivePerson Announces Fourth Quarter 2025 Financial Results

    -- Total Revenue of $59.3 million, above the high-end of our guidance range ---- Adjusted EBITDA above the high-end of our guidance range  --NEW YORK, March 12, 2026 /PRNewswire/ -- LivePerson, Inc. (NASDAQ:LPSN) ("LivePerson" the "Company", "we" or "us"), a leading provider of predictable conversational AI, today announced financial results for the fourth quarter ended December 31, 2025. Fourth Quarter HighlightsTotal revenue was $59.3 million for the fourth quarter of 2025, a decrease of 19% as compared to the same period last year, driven by customer cancellations and downsel

    3/12/26 4:30:00 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    LivePerson to Announce Fourth Quarter 2025 Financial Results on March 12, 2026

    NEW YORK, March 4, 2026 /PRNewswire/ -- LivePerson, Inc. (NASDAQ:LPSN), a leading provider of predictable conversational AI, today announced the planned release of its fourth quarter financial results after the market close on Thursday, March 12, 2026. CEO John Sabino and CFO & COO John Collins will host a conference call later that day, at 5:00 p.m. Eastern Time. The conference call will be simulcast live and can be accessed by logging onto the investor relations section of the Company's web site at ir.liveperson.com.To participate via telephone, callers should dial in five to

    3/4/26 4:30:00 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    Endava Announces Second Quarter Fiscal Year 2026 Results

    Q2 FY2026 5.9% Year on Year Revenue Decline to £184.1 million 5.1% Revenue Decline at Constant Currency Diluted EPS £(0.13) compared to £0.11 in the prior year comparative period Adjusted Diluted EPS £0.16 compared to £0.30 in the prior year comparative period Endava plc (NYSE:DAVA) ("Endava" or the "Company"), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced results for the three months ended December 31, 2025 ("Q2 FY2026"). "Over the past several quarters we have been investing heavily in our pivot towards AI to establish Endava as an AI leader. These investments have encompassed

    2/19/26 7:15:00 AM ET
    $DAVA
    EDP Services
    Technology

    $DAVA
    $ENVB
    $HAYW
    $KA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hayward Holdings Inc.

    SC 13G/A - Hayward Holdings, Inc. (0001834622) (Subject)

    11/22/24 4:06:52 PM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Hayward Holdings Inc.

    SC 13G/A - Hayward Holdings, Inc. (0001834622) (Subject)

    11/14/24 8:12:55 PM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology